actein
Small moleculeexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
2
Earliest trial started Sep 20, 2024 (NCT06688292)
Timeline
No events for the selected filters.
Indications
Mechanism of action
- Serine/threonine-protein kinase AKTINHIBITOR
AKT1 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06828120 | Phase 4 | Feb 20, 2025 | Government of China, Taipei Veteran General hospital |
| NCT06688292 | Phase 4 | Sep 20, 2024 | Government of China, Taichung Veterans General Hospital |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Government of China | Government | 2 | 2 | 1 | 2024 |
| Taichung Veterans General Hospital | Academic/Hospital | 1 | 0 | 1 | 2024 |
| Taipei Veteran General hospital | Government | 1 | 0 | 1 | 2025 |
3 organizations
Page 1 / 1